UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy

Cancer gene therapy, 2015-03, Vol.22 (3), p.154-162

2015

Volltextzugriff (PDF)

Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site

Cancer research (Chicago, Ill.), 1999-02, Vol.59 (4), p.911-917

1999

Volltextzugriff (PDF)

Oncolytic viruses: focusing on the tumor microenvironment

Cancer gene therapy, 2015-04, Vol.22 (4), p.169-171

2015

Volltextzugriff (PDF)

Interleukin 10 production by human melanoma

Clinical cancer research, 1996-08, Vol.2 (8), p.1383-1390

1996

Volltextzugriff (PDF)

De novo Decorin Gene Expression Suppresses the Malignant Phenotype in Human Colon Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 1995-07, Vol.92 (15), p.7016-7020

1995

Volltextzugriff (PDF)

PHASE I STUDY OF INTRAVESICAL VACCINIA VIRUS AS A VECTOR FOR GENE THERAPY OF BLADDER CANCER

The Journal of urology, 2001-10, Vol.166 (4), p.1291-1295

2001

Volltextzugriff (PDF)

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

Cancer gene therapy, 1999-09, Vol.6 (5), p.409-422

1999

Volltextzugriff (PDF)

Use of dendritic cells to immunize against cancers overexpressing p53

Clinical cancer research, 2001, Vol.7 (1), p.2-4

2001

Volltextzugriff (PDF)

Intralesional vaccinia/GM-CSF recombinant virus in the treatment of metastatic melanoma

Advances in experimental medicine and biology, 2000, Vol.465, p.391

2000

Volltextzugriff (PDF)

Intravesical gene therapy : in vivo gene transfer using recombinant vaccinia virus vectors

Cancer research (Chicago, Ill.), 1994-07, Vol.54 (13), p.3325-3328

1994

Volltextzugriff (PDF)

Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells

Cancer research (Chicago, Ill.), 1992-08, Vol.52 (15), p.4286-4290

1992

Volltextzugriff (PDF)

Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors

Cancer gene therapy, 2002-12, Vol.9 (12), p.1013-1021

2002

Volltextzugriff (PDF)

Gene therapy for human cancer: an essay for clinicians

Seminars in oncology, 1996-02, Vol.23 (1), p.4-21

1996

Volltextzugriff (PDF)

Poxvirus vectors: orphaned and underappreciated

The Journal of clinical investigation, 2000-04, Vol.105 (8), p.1031-1034

2000

Volltextzugriff (PDF)

Limiting dilution analysis of TNF producing cells in C3H/HeJ mice

The Journal of immunology (1950), 1988-11, Vol.141 (10), p.3422-3428

1988

Volltextzugriff (PDF)

Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses

Cancer research (Chicago, Ill.), 2003-05, Vol.63 (9), p.2150-2157

2003

Volltextzugriff (PDF)

Intravesical Growth of Murine Bladder Tumors Assessed by Transrectal Ultrasound

The Journal of urology, 1993-08, Vol.150 (2), p.525-528

1993

Volltextzugriff (PDF)

NEXT GENERATION VACCINE STRATEGIES FOR CANCER

The Journal of urology, 2000-04, Vol.163 (4), p.1069-1069

Lattime, Edmund C.

2000

Volltextzugriff (PDF)

Tumor growth in vivo selects for resistance to tumor necrosis factor

The Journal of immunology (1950), 1989-12, Vol.143 (12), p.4317-4323

1989

Volltextzugriff (PDF)

Expression of cytokine mRNA in human melanoma tissues

Cancer Immunology Immunotherapy, 1995-05, Vol.41 (3), p.151-156

1995

Volltextzugriff (PDF)

Development of Secondary Structure, Growth Characteristics and Cytogenetic Analysis of Human Transitional Cell Carcinoma Xenografts in Scid/Scid Mice

The Journal of urology, 1996-03, Vol.155 (3), p.1128-1132

1996

Volltextzugriff (PDF)

Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parameters

Cancer biotherapy & radiopharmaceuticals, 1998-02, Vol.13 (1), p.13-23

1998

Volltextzugriff (PDF)

Thymic lymphomas mediate non-MHC-restricted, TNF-dependent lysis of the murine sarcoma WEHI-164

Cellular immunology, 1991-08, Vol.136 (1), p.69-79

1991

Volltextzugriff (PDF)

L3T4+, B2A2+ thymocytes from infant mice produce IL 2 after interaction with accessory cells expressing self class II antigens

The Journal of immunology (1950), 1986-04, Vol.136 (8), p.2741-2746

1986

Volltextzugriff (PDF)

Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy

Cancer Immunology Immunotherapy, 1994-11, Vol.39 (6), p.401-406

1994

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(88)
Buchkapitel
(4)

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy

Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site

Oncolytic viruses: focusing on the tumor microenvironment

Interleukin 10 production by human melanoma

De novo Decorin Gene Expression Suppresses the Malignant Phenotype in Human Colon Cancer Cells

PHASE I STUDY OF INTRAVESICAL VACCINIA VIRUS AS A VECTOR FOR GENE THERAPY OF BLADDER CANCER

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

Use of dendritic cells to immunize against cancers overexpressing p53

Intralesional vaccinia/GM-CSF recombinant virus in the treatment of metastatic melanoma

Intravesical gene therapy : in vivo gene transfer using recombinant vaccinia virus vectors

Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells

Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors

Gene therapy for human cancer: an essay for clinicians

Poxvirus vectors: orphaned and underappreciated

Limiting dilution analysis of TNF producing cells in C3H/HeJ mice

Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses

Intravesical Growth of Murine Bladder Tumors Assessed by Transrectal Ultrasound

NEXT GENERATION VACCINE STRATEGIES FOR CANCER

Tumor growth in vivo selects for resistance to tumor necrosis factor

Expression of cytokine mRNA in human melanoma tissues

Development of Secondary Structure, Growth Characteristics and Cytogenetic Analysis of Human Transitional Cell Carcinoma Xenografts in Scid/Scid Mice

Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parameters

Thymic lymphomas mediate non-MHC-restricted, TNF-dependent lysis of the murine sarcoma WEHI-164

L3T4+, B2A2+ thymocytes from infant mice produce IL 2 after interaction with accessory cells expressing self class II antigens

Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy

Suchergebnisse filtern